Alsup Laurie Smaldone
CIK 1589602 · last filed 2026-06-26
Alsup Laurie Smaldone is a corporate insider who has filed 45 SEC Form 4 insider transactions across 6 companies since 2013. The most recent filing, for ARVN, was dated Jun 26, 2026. Current disclosed insider exposure totals $1.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.71M
6
45
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARVN | Director | 41,572 | $8.20 | $340.9K | $0 | 8 | 2026-06-26 |
| TBPH | Director | 80,989 | $16.89 | $1.37M | $0 | 10 | 2026-06-16 |
| BB | Director | — | $8.09 | — | $0 | 18 | 2024-06-26 |
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | — | $2.16 | — | $0 | 3 | 2023-08-31 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 3 | 2023-06-13 |
| HUMANIGEN, INC (KBIO) Delisted | Director | — | — | — | $0 | 2 | 2015-07-14 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | ARVN | Grant (A) | +15,527 | $0 | EDGAR |
| 2026-06-16 | TBPH | Grant (A) | +6,009 | $0 | EDGAR |
| 2025-06-27 | ARVN | Grant (A) | +16,025 | $0 | EDGAR |
| 2025-05-21 | TBPH | Grant (A) | +10,649 | $0 | EDGAR |
| 2024-06-26 | BB | Grant (A) | — | $0 | EDGAR |
| 2024-06-04 | BB | Grant (A) | — | $0 | EDGAR |
| 2024-05-31 | ARVN | Grant (A) | +5,899 | $0 | EDGAR |
| 2024-05-10 | TBPH | Grant (A) | +10,537 | $0 | EDGAR |
| 2024-04-05 | — | Disp (D) | — | $0 | |
| 2024-03-04 | BB | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.